Hemant Surgical Industries Ltd (543916) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543916 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

Hemant Surgical Inds Share Price

294.60 -0.05 -0.02%
as on 05-Dec'25 15:40

Hemant Surgical Industries Ltd (543916) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543916 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

DeciZen - make an informed investing decision on Hemant Surgical Inds

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Hemant Surgical Industries stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
47.24
Market Cap:
384.2 Cr.
52-wk low:
88.2
52-wk high:
367.1

Is Hemant Surgical Industries Ltd an attractive stock to invest in?

1. Is Hemant Surgical Industries Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Hemant Surgical Industries Ltd is a average quality company.

2. Is Hemant Surgical Industries Ltd undervalued or overvalued?

The key valuation ratios of Hemant Surgical Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Hemant Surgical Industries Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Hemant Surgical Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Hemant Surgical Inds:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Hemant Surgical Industries Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 15.7%14.8%14.5%15.2%11.6%14.3%32.9%45.2%29.9%16.6%-
Value Creation
Index
0.10.10.00.1-0.20.01.42.21.10.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 39.651.550.655.756.159.8104109106107107
Sales YoY Gr.-30%-1.8%10.1%0.8%6.5%73.3%5.4%-3.2%0.9%-
Adj EPS 2.62.82.93.52.73.610.68.67.86.56.2
YoY Gr.-6.1%5.8%20.8%-24.3%33.6%195.5%-18.5%-9.1%-17.4%-
BVPS (₹) 20.420.22123.725.126.741.130.452.660.387.6
Adj Net
Profit
0.60.80.91.10.91.13.46.68.26.88
Cash Flow from Ops. 00000-0.312.16.3-4.28.9-
Debt/CF from Ops. 00000-53.40.81.1-1.63.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 11.6%13.7%0.9%0.9%
Adj EPS 10.6%19.3%-15.1%-17.4%
BVPS12.8%19.2%13.7%14.8%
Share Price - - - 128%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
13.314.91515.81112.929.536.320.911.58.4
Op. Profit
Mgn %
5.94.74.94.84.65.96.19.79.99.7NAN
Net Profit
Mgn %
1.61.61.921.51.93.36.17.86.47.6
Debt to
Equity
2.31.91.31.51.81.70.70.30.10.5-
Working Cap
Days
2161501401421681711141321852550
Cash Conv.
Cycle
53321451830201735770

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 8.40%

Sales growth has been subdued in last 3 years 0.94%

Net Profit has been subdued in last 3 years -15.08%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Hemant Surgical Industries Ltd.

Standalone Consolidated
TTM EPS (₹) 6.2 6.2
TTM Sales (₹ Cr.) 107 107
BVPS (₹.) 87.6 87.7
Reserves (₹ Cr.) 101 101
P/BV 3.36 3.36
PE 47.24 47.78
From the Market
52 Week Low / High (₹) 88.15 / 367.10
All Time Low / High (₹) 88.15 / 367.10
Market Cap (₹ Cr.) 384
Equity (₹ Cr.) 13
Face Value (₹) 10
Industry PE 53.3

Management X-Ray of Hemant Surgical Inds:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Hemant Surgical Inds - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Hemant Surgical Inds

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales405151565660104109106107
Operating Expenses 37494853545797999597
Manufacturing Costs1111211222
Material Costs33444245444782807876
Employee Cost 1122235667
Other Costs 22455610111012
Operating Profit 222333611109
Operating Profit Margin (%) 5.9%4.7%4.9%4.8%4.6%5.1%6.1%9.7%9.9%8.6%
Other Income 0000012245
Interest 2211122212
Depreciation 0001111111
Exceptional Items 0000000000
Profit Before Tax 1111126101311
Tax 0000001232
Profit After Tax 11111158108
PAT Margin (%) 1.6%1.6%1.9%2.0%1.5%1.9%4.5%7.0%9.3%7.6%
Adjusted EPS (₹)2.62.82.93.52.73.614.49.99.47.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 56788913235563
Share Capital 222222281010
Reserves 34566711164453
Minority Interest0000000000
Debt1111911141395627
Long Term Debt335691043423
Short Term Debt8845534223
Trade Payables1091212151321242539
Others Liabilities 21124812121519
Total Liabilities 2827283341435465100147

Fixed Assets

Gross Block7678101616192447
Accumulated Depreciation3001145667
Net Fixed Assets 467891212131840
CWIP 00000000012
Investments 0000011051
Inventories11779151513152142
Trade Receivables67555416172220
Cash Equivalents 11214268139
Others Assets 6579898112122
Total Assets 2827283341435465100147

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 00000-0126-49
PBT 0000026101311
Adjustment 0000022414
Changes in Working Capital 00000-44-5-15-3
Tax Paid 00000-0-0-3-3-3
Cash Flow From Investing Activity 00000-2-0-3-12-30
Capex 00000-2-0-4-6-36
Net Investments 00000000-53
Others 00000001-23
Cash Flow From Financing Activity 000001-8-12118
Net Proceeds from Shares 000001-13220
Net Proceeds from Borrowing 000003-6-2020
Interest Paid 00000-2-2-2-1-2
Dividend Paid 0000000000
Others 00000-21-00-0
Net Cash Flow 00000-2435-4

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)13.3114.8914.9815.821113.8442.5641.8425.0613.8
ROCE (%)15.6614.7614.5115.2311.6414.3432.8945.1529.8716.58
Asset Turnover Ratio1.481.91.851.821.511.422.131.831.280.86
PAT to CFO Conversion(x)00000-02.40.75-0.41.13
Working Capital Days
Receivable Days48474434353035556772
Inventory Days1186552537891494662109
Payable Days11476909511410875102115153

Hemant Surgical Industries Ltd Stock News

Hemant Surgical Industries Ltd FAQs

The current trading price of Hemant Surgical Inds on 05-Dec-2025 15:40 is ₹294.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Hemant Surgical Inds stood at ₹384.2.
The latest P/E ratio of Hemant Surgical Inds as of 04-Dec-2025 is 47.24.
The latest P/B ratio of Hemant Surgical Inds as of 04-Dec-2025 is 3.36.
The 52-week high of Hemant Surgical Inds is ₹367.1 and the 52-week low is ₹88.15.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hemant Surgical Inds is ₹106.5 ( Cr.) .

About Hemant Surgical Industries Ltd

The company was originally incorporated as ‘Hemant Surgical Industries Private Limited’ under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated March 27, 1989, by Registrar of Companies, Maharashtra, Mumbai. Subsequently the company was converted into a public limited company vide special resolution passed by the shareholders at the Extra Ordinary General Meeting held on January 24, 1994 and the name of the company was changed from ‘Hemant Surgical Industries Private Limited’ to ‘Hemant Surgical Industries Limited’ vide fresh Certificate of Incorporation granted to the company consequent upon conversion into public limited company dated February 22, 1994 by the Registrar of Companies, Maharashtra, Mumbai.

The company manufactures, import, assemble and market a comprehensive portfolio of medical equipments and disposables. Its product offerings cover a wide spectrum of equipments and disposables required for (i) Renal Care, (ii) cardiovascular disease (iii) respiratory disease, (iv) Critical Care and Radiology and (v) Surgical disposables. Its wide range of products includes some of the indigenously manufactured products along with some other products that are imported from countries like: Japan, China France and Australia and are further processed in its assembly units. In addition it is also providing services for maintenance and running of dialysis centres.

The company started its operations with importing and marketing of medical disposables like: meditapes, all over India from JMS Company Japan. Later in the year 1999 the company started its manufacturing operations with one Manufacturing unit and over the years expanded its manufacturing and assembly operations to two more additional units. Its facilities are ISO 9001:2015 and ISO 13485:2016 certified having fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing and assembly line process. The company was founded in the year 1989 by one of its Promoters, Hanskumar Shamji Shah, who has over 35 years of experience in the industry.

Business of the company 

Hemant surgical Industries is engaged in the business of manufacturing, importing, assembly and marketing of medical equipments and disposables.

Products of the company

Healthcare products and medical equipments

  • Hemodialysis machine
  • Dialysis Solution - Acidic and bicarbonate
  • Dialyzer
  • ECG machine
  • ECG electrode
  • Nebulizer
  • Paramonitors
  • Ultrasound machine
  • Ventilator

Surgical disposables

  • Meditape
  • Intravenous infusion set
  • Scalp vein set
  • Foley catheter
  • 3 Ply masks

Other healthcare products

  • Digital thermometer
  • Cold and hot sterilant
  • Fully automatic comfort dialysis chair
  • Five-Function electric ICU bed with mattress

History and milestones

  • 1989: Incorporation of the company in the name of ‘Hemant Surgical Private Limted’.
  • 1993: Became the Sole Agent for JMS Co. Ltd, Japan, for JMS, Meditape.
  • 1994: Conversion into Public Limited company with the name Hemant Surgical Industries Ltd. 
  • 1999: Started its first manufacturing plant at Achhad, Maharashtra for External Preparation and Small Volume Parentals.
  • 2018: Entered into exclusive distribution agreement dated July 01, 2018, valid for a period of 6 years, with JMS Co. Ltd., Japan for importing and marketing JMS Meditape in India. The imported meditape undergoes the process of rewinding, slitting, and packaging in its assembly unit situated at Atgaon and is then sold in Indian market.
  • 2019: Entered into technical collaboration agreement with JMS Singapore Pte. Ltd. for manufacturing Intravenous Infusion Set which are sold under the brand name ‘JMS’ in India.
  • 2019: Signed exclusive distribution agreement with Hemant Phillipines Inc./ Mediply Inc. for supply of renal care equipment, medical devices and consumables for marketing the same in entire Phillipines.
  • 2021: Appointed as sole agent of SWS Hemodialysis Care Co. Ltd., Chinato sell and do maintenance of SWS4000A hemodialysis machines in West India on exclusive basis.
  • 2021: Entered into MOU with Dr. Venkatesh for setting up of dialysis centre at Guru Harikrishan Hospital 24x7 Dialysis Centre, New Delhi. 
  • 2022: Achieved a Bench mark of 100 Cr Turnover in the FY 2021-22.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×